Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer's disease

Detection of Alzheimer's Disease Biomarkers

Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort. - Abstract - Europe PMC

Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary

Fully automated chemiluminescence enzyme immunoassays showing high correlation with immunoprecipitation mass spectrometry assays for β-amyloid (1–40) and (1–42) in plasma samples - ScienceDirect

The global Alzheimer's Association round robin study on plasma amyloid β methods - Pannee - 2021 - Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring - Wiley Online Library

A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings

JPM, Free Full-Text

Age-dependent inverse correlations in CSF and plasma amyloid-β(1

Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort. - Abstract - Europe PMC

Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy